-
Secure Searches now available for ChEMBLdb, ChEMBL-NTD and Kinase SARfari
You can now access ChEMBLdb, ChEMBL-NTD and Kinase SARfari with the https protocol. This provides encrypted traffic between your web browser and also validates the identity of our server (so you know you are using the real ChEMBL site at the EMBL-EBI and not an imposter). Usage of all ChEMBL resources are also subject the the standard EMBL Terms of Use
You may wish to update any bookmarks you have saved to use these new urls.
The urls are:
https://www.ebi.ac.uk/chembldb for ChEMBLdb
and
https://www.ebi.ac.uk/chemblntd for ChEMBL-NTD
and
https://www.ebi.ac.uk/sarfari/kinasesarfari for Kinase SARfari
The standard http addresses will continue to work.
-
Part-time, Home-Based Curator - Biological Drugs
We are looking to appoint a part-time, home-based curator to cover biological drugs for the Open Access, Open Data drug discovery database ChEMBL. The role will require some previous experience of biological drug discovery and development, and a broad familiarity with the field. The biological drug portion of ChEMBL covers all classes of 'biotechnology' drugs, e.g. mAbs, aptamers, enzymes, peptides, solubilised receptors, etc. You will need to have your own computer and software (Excel, or OpenSource equivalent), bioinformatics experience, an investigative mind, and an eye for detail and thoroughness.
If you are interested in this opportunity, mail for further details - please attach a current cv. -
ChEMBL Schema and Interface Demos
A schema walkthrough, for those interested in dowloading the database and understanding the schema/data model - on Thursday 10th June at 3pm BST. Please click here to sign up.
A demonstration of the ChEMBL web-interface and its features - on Thursday 17th June at 3pm BST. Please click here to sign up.
We'll use webhuddle for the slides/demo. You don't need an account or any software, just a Java enabled web-browser. There will also be a separate number to dial into the audio.
-
Open Data for Neglected Tropical Disease Discovery, and Release of ChEMBL-04
It was clearly a slow news day in Swindon that day; but, in a way, wouldn't it be nice to live a place where this was big news. I for one, am glad the tortoise is OK (google with the headline and you'll get the full, detailed story).
Anyway, there are some significant publications in Nature this week on HTS screening and follow-up for Malaria screens (the papers are free content at the moment - Gamo et al, and Guiguemde et al. There are also some press releases for these papers and the public data release. We won't repeat the content of these formal things, but here provide some informal commentary...
The magic data pixies here at EMBL-EBI have been working hard and we have loaded all the data into the latest release of our SAR database - ChEMBL04. The data is now live in the web interface, and the ftp download of the whole database will be in the near future (we are still optimising our production processes, so sorry that the data is available in the front-end before the download files are fully ready and tested - but we took the view that people would probably not want us to hold back access where possible. However, the gap between loading into the front-end schema and the packaged export release will shorten.
We have also put together a 'microsite' called ChEMBL-NTD (NTD stands for Neglected Tropical Disease) accessible at http://www.ebi.ac.uk/chemblntd - this showcases and provides easy download of raw data from ChEMBL for this strategically important set of diseases, and also allows the addition of extra functionality for visualisation that isn't available in the ChEMBL front end. We have some exciting plans for community annotation of these data-sets, and more on this later. At the moment, there are download links, in a variety of common formats, for the GSK, St. Judes, and Novartis. Unfortunately we only had time to build some interactive query tools for the ChEMBL plasmodium and GSK datasets; but rest assured, were putting together some tools for cross datasets analysis and querying (given the scientific limits of analysis of large sets of single point screening data).
As you will probably guess, there are more data-sets in the pipeline for release, and we would be delighted if others with similar datasets would be interested in publicly archiving them here at the EMBL-EBI. As always, all the EMBL-EBI data is freely accessible, redistributable, etc>.
If you have any feedback on data formats, the interface, etc please let us know.
Chembl04 contains 680,293 compound records, 565,243 distinct compounds, and 2,705,136 assay data points.
Finally, a heartfelt thanks to many people who have helped us put this together, championed the release of data from their organisations, and acted as the social glue that is so important in getting these sort of things actually done. As the youth the world over now say - respect to Rick Keenan, Jose Garcia-Bustos, Frederic Bost, Pascal Fantauzzi, Richard Glynne, Thierry Diagana, Anang Shelat and Kip Guy!
%T Thousands of chemical starting points for antimalarial lead identification %J Nature %V 465 %P 305-310 %D 2010 %A F.-J. Gamo %A L.M. Sanz %A J. Vidal %A C. de Cozar %A E. Alvarez %A J.-L. Lavandera %A D.E. Vanderwall %A D.V.S. Green %A V. Kumar %A S. Hasan %A J.R. Brown %A C.E. Peishoff %A L.R. Cardon %A J.F. Garcia-Bustos %T Chemical genetics of Plasmodium falciparum %J Nature %V 465 %P 311-315 %A W.A. Guiguemde %A A.A. Shelat %A D. Bouck %A S. Duffy %A G.J. Crowther %A P.H. Davis %A D.C. Smithson %A M. Connelly %A J. Clark %A F. Zhu %A M.B. Jimnez-Dıaz %A M.S. Martinez %A E.B. Wilson %A A.K. Tripathi %A J. Gut %A E.R. Sharlow %A I. Bathurst %A F. El Mazouni1 %A J.W. Fowble %A I. Forquer %A P.L. McGinley %A S. Angulo-Barturen %A S. Ferrer %A P.J. Rosenthal %A J.L. DeRisi %A D.J. Sullivan Jr. %A J.S. Lazo %A D.S. Roos %A M.K. Riscoe %A M.A. Phillips %A P.K. Rathod %A W.C. Van Voorhis %A V.M. Avery %A R.K. Guy
-
Enhanced Interface For ChEMBL Now Available
Thanks for all the feedback so far on the interface and usability on the ChEMBL interface; we have been working hard and are pleased to announce the release of a significantly enhanced interface. As regular users will rapidly see, there is a completely new tabbed interface structure, and many other enhancements scattered over many parts of the system.
We also greatly appreciate the reporting of any errors in the data contained within the database - so please keep it up, your work benefits the entire community.
We are also making progress on porting the chemical infrastructure to the fantastic OrChem Open Source chemistry plugin for Oracle databases. An Open Access publication for OrChem can be found here. Watch this space for more news.
-
Informatics to support biological drug discovery
The Industry Programme at the EMBL-EBI is currently planning a ca. 40 attendee workshop later in the year to cover informatics methods and resources used in the discovery of biological drugs. We currently plan to cover a review of historic biological drug discovery, review attrition for biological drugs, patent databases, mAb structure and engineering, enzyme replacement therapies and replacement therapies, methods to address immunogenicity, solubilised receptors, RNA and aptamer-based therapeutics, etc. Experts from industry and academia will present to the various subjects.
We would greatly welcome ideas for inclusion in the workshop, volunteers for speaking, and so forth, also we would like to hear from you if you're potentially interested in attending.
-
Spanish Postdoctoral Fellowships
There is a scheme to fund gifted Spanish (nationals or residents) researchers at EMBL - details are on the following link. The chEMBL group would welcome to host researchers in suitable areas (bioinformatics applied to drug discovery, chemogenomics, knowledge discovery from data for pharmaceutical data, etc.) The deadline is May 29th 2010!
-
ChEMBL_03 now available on ftp site
Chembl_03 is now available for download from the ftp site. We will also add new releases to the new BioTorrents network (probably complete once we get the hang of this new fangled Internets - many thanks to Egon for his input and advice!).